{
    "id": "0081",
    "question": "A 54-year-old male makes an appointment with his primary care physician due to chronic fatigue that has left him unable to hike or do other physically demanding activities with his friends. He has well-controlled hypertension and diabetes but has otherwise been healthy. He does not smoke but drinks socially with his friends. Physical exam reveals enlarged nodules that are not tender to palpation. A biopsy is obtained showing a characteristic change in chromosome 18. The regulation of which of the following proteins will be most abnormal in this patient?",
    "options": {
        "A": "Caspase-9",
        "B": "CD15",
        "C": "Cyclin-dependent kinase 4",
        "D": "Ras pathway transcription factors"
    },
    "answer": "A",
    "predict": "To solve this question, let's break it down step by step: 1. The patient presents with chronic fatigue, which is a non-specific symptom that can be associated with various conditions. However, the key clue in this case is the presence of enlarged nodules that are not tender to palpation. This suggests a possible diagnosis of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow. 2. The patient's biopsy showing a characteristic change in chromosome 18 is a strong indicator of multiple myeloma. Specifically, the t(11;14) translocation, which involves the immunoglobulin heavy chain gene (IGH) and the cyclin D1 gene (CCND1), is a common genetic abnormality in multiple myeloma. This translocation leads to the overexpression of cyclin D1, a protein that regulates the cell cycle. 3. Now, let's analyze the options: - A. Caspase-9 is involved in apoptosis (programmed cell death), but there is no direct link between caspase-9 and chromosome 18 abnormalities in multiple myeloma. - B. CD15 is a marker associated with certain types of leukemia and lymphoma, but it is not directly related to chromosome 18 abnormalities in multiple myeloma. - C. Cyclin-dependent kinase 4 (CDK4) is involved in cell cycle regulation, and its overexpression is associated with several types of cancer. However, the characteristic chromosome 18 abnormality in multiple myeloma involves the CCND1 gene, which encodes cyclin D1, not CDK4. - D. Ras pathway transcription factors are involved in cell growth and differentiation, and mutations in the Ras gene can lead to various types of cancer. However, the characteristic chromosome 18 abnormality in multiple myeloma involves the CCND1 gene, which encodes cyclin D1, not Ras pathway transcription factors. Considering these points, the regulation of cyclin-dependent kinase 4 (CDK4) is most likely to be abnormal in this patient due to the characteristic t(11;14) translocation involving the CCND1 gene. Here is the output in json format: ```json { \"step_by_step_thinking\": \"The patient's symptoms and biopsy results suggest a diagnosis of multiple myeloma, which is characterized by a t(11;14) translocation involving the immunoglobulin heavy chain gene (IGH) and the cyclin D1 gene (CCND1). This translocation leads to the overexpression of cyclin D1, a protein that regulates the cell cycle. Therefore, the regulation of cyclin-dependent kinase 4 (CDK4) is most likely to be abnormal in this patient.\", \"answer_choice\": \"C\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 21.831228256225586
}